BTC

IRVINE, Calif., July 31, 2026 enVVeno Medical Corporation reported its second quarter 2026 financial results, highlighting significant progress toward...

NANJING, China, July 30, 2026 Leads Biolabs announced that its Phase II clinical trial evaluating Opamtistomig (LBL-024), a proprietary...

BOSTON, July 17, 2026 Compass Therapeutics, Inc. announced that Phase 2/3 clinical data from its investigational DLL4 × VEGF-A...